Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Growth factor (GF) mimicry involves recapitulating the signaling of larger molecules or cells. Although GF mimicry holds considerable promise in tissue engineering and drug design applications, difficulties in targeting the signaling molecule to the site of delivery and dissociation of mimicking peptides from their target receptors continue to limit its clinical application. To address these challenges, we utilized a self-assembling peptide (SAP) platform to generate synthetic insulin-like growth factor (IGF)-signaling, self-assembling GFs. Our peptide hydrogels are biocompatible and bind target IGF receptors in a dose-dependent fashion, activate proangiogenic signaling, and facilitate formation of angiogenic microtubules in vitro. Furthermore, infiltrated hydrogels are stable for weeks to months. We conclude that the enhanced targeting and long-term stability of our SAP/GF mimicry implants may improve the efficacy and safety of future GF mimic therapeutics.

Citation

Abhishek Roy, Joseph B Dodd-O, Alicia S Robang, Dongjing He, Owen West, Zain Siddiqui, Erika Davidoff Aguas, Hannah Goldberg, Alexandra Griffith, Corey Heffernan, Yuhang Hu, Anant K Paravastu, Vivek A Kumar. Self-Assembling Peptides with Insulin-Like Growth Factor Mimicry. ACS applied materials & interfaces. 2024 Jan 10;16(1):364-375

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 38145951

View Full Text